Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-24 @ 6:40 PM
NCT ID:
NCT01977157
Brief Summary:
Examination if the bioimpendanz measurement can be used for the determination of the alcohol content in human blood.
Furthermore the blood alcohol content (BAC) will be estimated by an official breathalyzer and one blood test.
Detailed Description:
In this clinical trail it will be analyzed, if it is possible to assess the blood alcohol content (BAC) with the bioimpedance devices (SFB7, ImpediMed; Nicomo).
This technology is non-invasive an can be measured by using conductive electrodes, capacitive electrodes or inductive measurement systems.
The BIS-values will be compared with an official breathanalyzer (Alcotest 7110 Evidential MK III, Dräger, Lübeck, Germany).
Furthermore one blood sample will be taken and analyzed with the ADH method as the current gold standard at the end of the trail.
Study:
NCT01977157
Study Brief:
Protocol Section:
NCT01977157